2019
Report from the European Society of Thoracic Surgeons prospective thymic database 2017: a powerful resource for a collaborative global effort to manage thymic tumours
Ruffini E, Guerrera F, Brunelli A, Passani S, Pellicano D, Thomas P, Van Raemdonck D, Rocco G, Venuta F, Weder W, Detterbeck F, Falcoz PE. Report from the European Society of Thoracic Surgeons prospective thymic database 2017: a powerful resource for a collaborative global effort to manage thymic tumours. European Journal Of Cardio-Thoracic Surgery 2019, 55: 601-609. PMID: 30649256, DOI: 10.1093/ejcts/ezy448.Peer-Reviewed Original ResearchConceptsNeuroendocrine thymic tumoursThymic tumorsAdjuvant treatmentThymic carcinomaStage IStage IIIB tumorsEuropean SocietyStage IV tumorsOverall recurrence rateInvasive surgical approachNew International AssociationCollaborative global effortIIIB tumorsProspective databaseStage IIIAMetastasis classificationRecurrence rateGroup tumorsRare tumorSurgical approachRetrospective databaseInvasive techniquesStage IIIPatientsTumors
2018
Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims. An Official American Thoracic Society Policy Statement
Leone FT, Carlsen KH, Chooljian D, Crotty Alexander LE, Detterbeck FC, Eakin MN, Evers-Casey S, Farber HJ, Folan P, Kathuria H, Latzka K, McDermott S, McGrath-Morrow S, Moazed F, Munzer A, Neptune E, Pakhale S, Sachs DPL, Samet J, Sufian B, Upson D. Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims. An Official American Thoracic Society Policy Statement. American Journal Of Respiratory And Critical Care Medicine 2018, 198: e90-e105. PMID: 30320525, PMCID: PMC6943880, DOI: 10.1164/rccm.201808-1443st.Peer-Reviewed Original ResearchIncorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement
Rivera MP, Tanner NT, Silvestri GA, Detterbeck FC, Tammemägi MC, Young RP, Slatore CG, Caverly TJ, Boyd CM, Braithwaite D, Fathi JT, Gould MK, Iaccarino JM, Malkoski SP, Mazzone PJ, Tanoue LT, Schoenborn NL, Zulueta JJ, Wiener RS. Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. American Journal Of Respiratory And Critical Care Medicine 2018, 198: e3-e13. PMID: 30004250, DOI: 10.1164/rccm.201805-0986st.Peer-Reviewed Original ResearchConceptsLung cancer screeningRisk of deathPatient selectionChronic illnessCancer screeningLung cancerOfficial American Thoracic Society Research StatementHarms of LCSImplementation of LCSScreen-detected lung cancersChronic obstructive pulmonary diseaseRisk of comorbiditiesObstructive pulmonary diseaseEffect of comorbidityLung cancer deathsTreatment-related harmsLung cancer riskBalance of benefitsPulmonary diseaseCancer deathBaseline riskCancer riskComorbiditiesHealthy individualsInternational clinicians
2017
Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement
Kathuria H, Detterbeck FC, Fathi JT, Fennig K, Gould MK, Jolicoeur DG, Land SR, Massetti GM, Mazzone PJ, Silvestri GA, Slatore CG, Smith RA, Vachani A, Zeliadt SB, Wiener RS. Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement. American Journal Of Respiratory And Critical Care Medicine 2017, 196: 1202-1212. PMID: 29090963, PMCID: PMC6072613, DOI: 10.1164/rccm.201709-1858st.Peer-Reviewed Original ResearchMeSH KeywordsBiomedical ResearchHumansLung NeoplasmsMass ScreeningSmoking CessationSocieties, MedicalTobacco Use DisorderUnited StatesConceptsLung cancer screening settingLung cancer screeningSmoking cessation interventionCessation interventionsCancer screeningScreening settingOfficial American Thoracic Society Research StatementComputed tomography lung cancer screeningLow-dose computed tomography (LDCT) lung cancer screeningEvidence-based smoking cessation interventionsLDCT lung cancer screeningTomography lung cancer screeningLung cancer screening programsEffective smoking cessation interventionsMultiple clinical practice guidelinesCancer screening programsTobacco dependence treatmentClinical practice guidelinesAmerican Thoracic SocietyTesting of interventionsImplementation of interventionsCessation counselingSmoking cessationLung cancerDependence treatmentComparison of surgical approach and extent of resection for Masaoka-Koga Stage I and II thymic tumours in Europe, North America and Asia: an International Thymic Malignancy Interest Group retrospective database analysis†
Fang W, Yao X, Antonicelli A, Gu Z, Detterbeck F, Vallières E, Aye RW, Farivar AS, Huang J, Shang Y, Louie BE. Comparison of surgical approach and extent of resection for Masaoka-Koga Stage I and II thymic tumours in Europe, North America and Asia: an International Thymic Malignancy Interest Group retrospective database analysis†. European Journal Of Cardio-Thoracic Surgery 2017, 52: 26-32. PMID: 28329118, PMCID: PMC6279116, DOI: 10.1093/ejcts/ezx042.Peer-Reviewed Original ResearchConceptsExtent of resectionThymic tumorsStage IAsian patientsSurgical approachOnly independent predictive factorMasaoka-Koga stage IMore stage IOutcomes of patientsPathological stage IIndependent predictive factorsIndependent risk factorOverall survival rateCumulative recurrence rateSmaller tumor sizeRetrospective database analysisNorth American patientsPartial thymectomyAdjuvant therapyParaneoplastic syndromeThymic carcinomaOverall survivalPerformance statusComplete resectionMyasthenia gravis
2015
Multimodality therapy for locally advanced thymomas: A propensity score–matched cohort study from the European Society of Thoracic Surgeons Database
Leuzzi G, Rocco G, Ruffini E, Sperduti I, Detterbeck F, Weder W, Venuta F, Van Raemdonck D, Thomas P, Facciolo F, Group E. Multimodality therapy for locally advanced thymomas: A propensity score–matched cohort study from the European Society of Thoracic Surgeons Database. Journal Of Thoracic And Cardiovascular Surgery 2015, 151: 47-57.e1. PMID: 26403869, DOI: 10.1016/j.jtcvs.2015.08.034.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAsiaChemotherapy, AdjuvantChildChi-Square DistributionDatabases, FactualDisease ProgressionDisease-Free SurvivalEuropeFemaleHumansKaplan-Meier EstimateMaleMiddle AgedMultivariate AnalysisNeoadjuvant TherapyNeoplasm Recurrence, LocalNeoplasm StagingNorth AmericaPropensity ScoreProportional Hazards ModelsRadiotherapy, AdjuvantRetrospective StudiesRisk AssessmentRisk FactorsSocieties, MedicalThymectomyThymomaThymus NeoplasmsTime FactorsTreatment OutcomeTumor BurdenYoung AdultConceptsRelapse-free survivalAdvanced thymomaMultimodality therapyOverall survivalT classificationPropensity score-matched cohort studyMultivariate Cox proportional hazards modelPropensity score-matched analysisCox proportional hazards modelPathologic T classificationStage III thymomaThoracic Surgeons databaseSignificant survival advantageSpecific pathologic featuresStrong predictive factorProportional hazards modelInduction therapyAdjuvant therapyPT3 tumorsCohort studyIndependent predictorsPrognostic impactMultivariable analysisPathologic featuresPredictive factors
2012
American College of Chest Physicians and Society of Thoracic Surgeons Consensus Statement for Evaluation and Management for High-Risk Patients With Stage I Non-small Cell Lung Cancer
Donington J, Ferguson M, Mazzone P, Handy J, Schuchert M, Fernando H, Loo B, Lanuti M, de Hoyos A, Detterbeck F, Pennathur A, Howington J, Landreneau R, Silvestri G, Surgeons F. American College of Chest Physicians and Society of Thoracic Surgeons Consensus Statement for Evaluation and Management for High-Risk Patients With Stage I Non-small Cell Lung Cancer. CHEST Journal 2012, 142: 1620-1635. PMID: 23208335, DOI: 10.1378/chest.12-0790.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerStage I non-small cell lung cancerHigh-risk patientsCell lung cancerChest PhysiciansTreatment optionsLung cancerAmerican CollegeStereotactic body radiation therapySevere medical comorbiditiesThoracic Oncology NetworkAlternative treatment optionMore indolent tumorsBody radiation therapyRisk-benefit decisionsInterventional riskMedical comorbiditiesNonoperative therapyRespiratory failureInvolved lobeMediastinal lymphProcedural morbidityRegional recurrenceSublobar resectionRadiographic stagingThe Lung Cancer Stage Page There When You Need It—StagingLungCancer.org
Kim AW, Johnson KM, Detterbeck FC. The Lung Cancer Stage Page There When You Need It—StagingLungCancer.org. CHEST Journal 2012, 141: 581-586. PMID: 22396557, DOI: 10.1378/chest.11-3192.Peer-Reviewed Original Research
2011
Management of Thymic Tumors: A Survey of Current Practice among Members of the European Society of Thoracic Surgeons
Ruffini E, Van Raemdonck D, Detterbeck F, Rocco G, Thomas P, Venuta F, Group T. Management of Thymic Tumors: A Survey of Current Practice among Members of the European Society of Thoracic Surgeons. Journal Of Thoracic Oncology 2011, 6: 614-623. PMID: 21266921, DOI: 10.1097/jto.0b013e318207cd74.Peer-Reviewed Original ResearchConceptsThymic tumorsPreoperative assessmentTomography scanThoracic surgeonsPositron emission tomography scanWorld Health Organization classificationRole of surgeryStage IVA thymomaEuropean SocietyEmission tomography scanManagement of thymomasESTS membersReliable staging systemType C thymomasAreas of controversyIVA thymomaExtrapleural pneumonectomyExtended resectionRecurrent diseasePostoperative treatmentThymic malignanciesHistologic confirmationStaging systemOrganization classificationObservational study